Skip to main content
. 2021 Apr 8;12:2105. doi: 10.1038/s41467-021-22212-1

Fig. 6. Symbiotic metabolism.

Fig. 6

Low-molecular metabolites produced by the intestinal microbiota remain in the lumen (Metabolite A) or are absorbed from the intestinal lumen to systemic circulation (Metabolite B and C). Metabolite B, which are represented by short-chain fatty acids, directory act on host cells to exert physiological activities. Meanwhile, a part of inactive metabolites may be further converted to bioactive substances via host metabolic pathways after absorption (Metabolite C). The entities of such symbiotic metabolism, however, remain obscure. Our study using gnotobiotic mice demonstrated that microbial putrescine is uptaken by the colonic epithelial cells to produce bioactive spermidine that accelerates epithelial renewal and increases the abundance of anti-inflammatory macrophages in the colon. Thus, microbial putrescine serves as a source (precursor) of bioactive substances in the host animals. This observation provides evidence for symbiotic metabolism contributing to the maintenance of intestinal homoeostasis.